Skip to content
★ Sign in to follow
JM
Total declarations
26
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€11.6M

Latest filing published 24 Sept 2018 for Axogen, Inc., €28k.

Filing timeline

BuySale
Jamie Mark Grooms

Insider track record

Disclosed buys
0
Disclosed sells
21
Signal history

Jamie Mark Grooms: trading record in brief

Jamie Mark Grooms discloses dealings in Axogen, Inc. to SEC (Form 4). In total, 26 filings cover trades dated from 10 October 2011 to 20 September 2018.

The open-market record consists of 21 sales worth €11.6M, with no purchase. Other entries cover 2 share grants and 3 option exercises. Since January 2018: no purchases and 13 sales on the market.

Most recently, on 24 September 2018, the filings show an option exercise worth €28k in Axogen, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Jamie Mark Grooms

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total
  • ◇
    DirectorExecutivesAxogen, Inc.
    33,000 USD11SEC
    12,000 shares@ US$2.750.2% of flowCommon StockSEC:0001179110-18-011633:1
  • ◇
    DirectorExecutivesAxogen, Inc.
    133 USD11SEC
    494 shares@ US$0.270.0% of flowCommon StockSEC:0001179110-18-011633:0
  • ▼
    DirectorExecutivesAxogen, Inc.
    2M USD13SEC
    57,406 shares@ US$28.4015.9% of flowCommon StockSEC:0001104659-18-011770:0
  • ▼
    DirectorExecutivesAxogen, Inc.
    729,014 USD12SEC
    26,655 shares@ US$27.357.0% of flowCommon StockSEC:0001104659-18-010876:0
  • ▼
    DirectorExecutivesAxogen, Inc.
    1M USD12SEC
    36,740 shares@ US$27.909.9% of flowCommon StockSEC:0001104659-18-010876:1
  • ▼
    VP, CFOExecutivesAxogen, Inc.
    186,020 USD19SEC
    7,100 shares@ US$26.201.8% of flowCommon StockSEC:0001104659-18-010127:0
  • ▼
    VP, CFOExecutivesAxogen, Inc.
    83,904 USD19SEC
    3,200 shares@ US$26.220.8% of flowCommon StockSEC:0001104659-18-010127:1
  • ▼
    VP, CFOExecutivesAxogen, Inc.
    880,050 USD20SEC
    32,936 shares@ US$26.728.5% of flowCommon StockSEC:0001104659-18-010127:2
  • ▼
    VP, CFOExecutivesAxogen, Inc.
    1M USD20SEC
    43,403 shares@ US$27.1111.3% of flowCommon StockSEC:0001104659-18-010127:4
  • ▼
    VP, CFOExecutivesAxogen, Inc.
    242,340 USD19SEC
    9,073 shares@ US$26.712.4% of flowCommon StockSEC:0001104659-18-010127:3
  • ▼
    DirectorExecutivesAxogen, Inc.
    886,745 USD27SEC
    33,500 shares@ US$26.479.0% of flowCommon StockSEC:0001179110-17-015343:1
  • ▼
    DirectorExecutivesAxogen, Inc.
    436,849 USD26SEC
    16,585 shares@ US$26.344.5% of flowCommon StockSEC:0001179110-17-015344:1
  • ▼
    DirectorExecutivesAxogen, Inc.
    574,957 USD27SEC
    21,820 shares@ US$26.355.9% of flowCommon StockSEC:0001179110-17-015344:0
  • ▼
    DirectorExecutivesAxogen, Inc.
    558,224 USD27SEC
    21,290 shares@ US$26.225.7% of flowCommon StockSEC:0001179110-17-015168:0
  • ▼
    DirectorExecutivesAxogen, Inc.
    826,800 USD27SEC
    31,200 shares@ US$26.508.4% of flowCommon StockSEC:0001179110-17-015168:1
  • ▼
    DirectorExecutivesAxogen, Inc.
    838,698 USD27SEC
    31,805 shares@ US$26.378.5% of flowCommon StockSEC:0001179110-17-015168:2
  • ◇
    DirectorExecutivesAxogen, Inc.
    3,882 USD11SEC
    14,379 shares@ US$0.270.0% of flowCommon StockSEC:0001179110-17-013746:0
  • ◆
    DirectorExecutivesAxogen, Inc.
    3,893 USD11SEC
    189 shares@ US$20.600.0% of flowCommon StockSEC:0001179110-17-013746:1
  • ◆
    DirectorExecutivesAxogen, Inc.
    15,001 USD0SEC
    5,455 shares@ US$2.75Common StockSEC:0001209191-11-051596:0

19 of 19 declarations